Clinical Microbiology & Infection

The changing global epidemiology of Acinetobacter baumannii infections: a development with major public health implications
pp. 117-119(3)
Authors: Falagas, M. E.; Karveli, E. A.

Molecular evolution of Mycobacterium tuberculosis
pp. 120-128(9)
Author: Arnold, C.

Molecular epidemiology and prevalence of mutations conferring rifampicin and isoniazid resistance in Mycobacterium tuberculosis strains from the southern Ukraine
pp. 129-138(10)
Authors: Nikolayevskyy, V. V.; Brown, T. J.; Bazhora, Y. I.; Asmolov, A. A.; Balabanova, Y. M.; Drobniewski, F. A.

PPE protein (Rv3425) from DNA segment RD11 of Mycobacterium tuberculosis: a potential B-cell antigen used for serological diagnosis to distinguish vaccinated controls from tuberculosis patients
pp. 139-145(7)
Authors: Zhang, H.; Wang, J.; Lei, J.; Zhang, M.; Yang, Y.; Chen, Y.; Wang, H.

The RD1-encoded antigen Rv3872 of Mycobacterium tuberculosis as a potential candidate for serodiagnosis of tuberculosis
pp. 146-152(7)
Authors: Mukherjee, P.; Dutta, M.; Datta, P.; Dasgupta, A.; Pradhan, R.; Pradhan, M.; Kundu, M.; Basu, J.; Chakrabarti, P.

Clinical characterisation of pneumonia caused by atypical pathogens combining classic and novel predictors
pp. 153-161(9)
Authors: Masiá, M.; Gutiérrez, F.; Padilla, S.; Soldán, B.; Mirete, C.; Shum, C.; Hernández, I.; Royo, G.; Martin-Hidalgo, A.

Clinical and bacteriological outcomes in hospitalised patients with community-acquired pneumonia treated with azithromycin plus ceftriaxone, or ceftriaxone plus clarithromycin or erythromycin: a prospective, randomised, multicentre study
pp. 162-171(10)
Authors: Tamm, M.; Todisco, T.; Feldman, C.; Garbino, J.; Blasi, F.; Hogan, P.; de Caprariis, P. J.; Hoepelman, I. M.

Pertussis in young infants: apnoea and intra-familial infection
pp. 172-175(4)
Authors: Raymond, J.; Armengaud, J.-B.; Cosnes-Lambe, C.; Chalumeau, M.; Bosdure, E.; Reglier-Poupet, H.; El Hajje, M.-J.; Iniguez, J.-L.; Moulin, F.; Poyart, C.; Gendrel, D.

Molecular characterisation of a coxsackievirus A24 that caused an outbreak of acute haemorrhagic conjunctivitis, Tunisia 2003
pp. 176-182(7)
Authors: Triki, H.; Rezig, D.; Bahri, O.; Ben Ayed, N.; Ben Yahia, A.; Sadraoui, A.; Ayed, S.

Genetic analysis of mechanisms of multidrug resistance in a clinical isolate of Bacteroides fragilis
pp. 183-189(7)
Authors: Pumbwe, L.; Wareham, D. W.; Aduse-Opoku, J.; Brazier, J. S.; Wexler, H. M.

Identification of widespread, closely related Acinetobacter baumannii isolates in Portugal as a subgroup of European clone II
pp. 190-195(6)
Authors: Da Silva, G.; Dijkshoorn, L.; van der Reijden, T.; van Strijen, B.; Duarte, A.

Multidrug-resistant Acinetobacter baumannii bacteraemia: clinical features, antimicrobial therapy and outcome
pp. 196-198(3)
Authors: Kuo, L.-C.; Lai, C.-C.; Liao, C.-H.; Hsu, C.-K.; Chang, Y.-L.; Chang, C.-Y.; Hsueh, P.-R.

Treatment of infections caused by metallo-β-lactamase-producing Pseudomonas aeruginosa in the Calgary Health Region
pp. 199-202(4)
Authors: Parkins, M. D.; Pitout, J. D. D.; Church, D. L.; Conly, J. M.; Laupland, K. B.

Activity of imipenem against VIM-1 metallo-β-lactamase-producing Klebsiella pneumoniae in the murine thigh infection model
pp. 202-205(4)
Authors: Daikos, G. L.; Panagiotakopoulou, A.; Tzelepi, E.; Loli, A.; Tzouvelekis, L. S.; Miriagou, V.

Patient and bacterial determinants involved in symptomatic urinary tract infection caused by Escherichia coli with and without bacteraemia
pp. 205-208(4)
Authors: Venier, A. G.; Talon, D.; Patry, I.; Mercier-Girard, D.; Bertrand, X.

A comparison of phylogenetic group, virulence factors and antibiotic resistance in Russian and Norwegian isolates of Escherichia coli from urinary tract infection
pp. 208-211(4)
Authors: Grude, N.; Potaturkina-Nesterova, N. I.; Jenkins, A.; Strand, L.; Nowrouzian, F. L.; Nyhus, J.; Kristiansen, B.-E.

Linezolid therapy for infective endocarditis
pp. 211-215(5)
Authors: Muñoz, P.; Rodríguez-Creixéms, M.; Moreno, M.; Marín, M.; Ramallo, V.; Bouza, E.

Escherichia coli aortic valve endocarditis
pp. 216-216(1)
Authors: Zavascki, A. P.; Morelle, A. M.

Evaluation of seven commercial antigen detection tests for Giardia and Cryptosporidium in stool samples
pp. 217-217(1)
Authors: Weitzel, T.; Dittrich, S.; Möhl, I.; Adusu, E.; Jelinek, T.

Pandrug-resistant Pseudomonas aeruginosa among hospitalised patients: clinical features, risk-factors and outcomes
pp. 217-217(1)
Authors: Wang, C. Y.; Jerng, J. S.; Cheng, K. Y.; Lee, L. N.; Yu, C. J.; Hsueh, P. R.; Yang, P. C.